Partek and Ion Torrent Announce Partnership to Deliver
Scalable Software Solutions for Ion Torrent Sequencing
Best-in-Class Bioinformatics Software a Complementary Addition to
Ion Torrent's Semiconductor-based, Next-Generation Sequencing Technology
ST. LOUIS â€” Feb. 3, 2011 â€” Partek Incorporated, a global leader in bioinformatics software, today announced the signing of a distribution agreement with Ion Torrent Systems, Inc., a provider of next-generation DNA sequencing technology. The agreement makes PartekÂ® Genomics Suiteâ„¢ available directly through Ion Torrent's online store as a featured solution for analyzing data generated by Ion Torrent's next generation sequencing (NGS) devices.
"Ion Torrent's vision has always been to democratize sequencing with a system that is fast, simple and scalable so that everyone has access to sequencing technology," said Mike Lelivelt, Ph.D., Director of Bioinformatics and Software Products at Ion Torrent. "Partek shares that vision. They build software that makes sequence analysis simple and accessible to everyone, and that makes this partnership a great fit for everyone, especially customers."
Leveraging an 18-year commercial historyâ€”founded on sound statistical analysis and more than a decade of microarray analysisâ€”Partek Genomics Suite is a comprehensive solution for the analysis, comparison and integration of the massive amounts of genomic data that can now be readily produced using semiconductor-based sequencing. Used by thousands of scientists worldwide at leading universities, hospitals, government institutions, biotechnology firms and pharmaceutical companies, Partek Genomics Suite was cited in more than one peer-reviewed publication per day in 2010. It is unique in its ability to support all microarray and next generation sequencing technologies for RNA-, DNA- and gene regulation applications in a single software package, allowing also for the integration of multiple applications in a user-friendly way.
"Partek has a great working relationship with Ion Torrent, and we're pleased to have reached this agreement," said Tom Downey, President of Partek. "The Ion Personal Genome Machine (PGMâ„¢) is increasing accessibility to genomic sequencing, resulting in new data that has to be interpreted to be useful. Partek continues to be on the forefront of providing the necessary tools to streamline and simplify the analysis of genomic data such as product by Ion Torrent's semiconductor sequencing technology."
Partek Incorporated (www.partek.com) develops and globally markets quality software for life sciences research. Its flagship product, PartekÂ® Genomics Suiteâ„¢, provides innovative solutions for integrated genomics. Partek Genomics Suite is unique in supporting all major microarray and next generation sequencing platforms. Workflows offer streamlined analysis for: Gene Expression (incl. SAGE), miRNA Expression, Exon, Copy Number, Allele Specific Copy Number, LOH, Association, Trio analysis, Tiling, ChIP-Seq, RNA-Seq, DNA-Seq, DNA Methylation and qPCR. Since 1993, Partek, headquartered in St. Louis, Missouri USA, has been turning data into discoveryÂ®.
# # #
Partek and Genomics Suite are trademarks of Partek Incorporated. The names of other companies and products mentioned herein may be the trademarks of their respective owners.